In the run-up to the 2026 midterm elections, the political parties in many states are working to redefine their congressional district maps to gain every possible edge. From California and Texas to Tennessee and Virginia, redistricting efforts have taken center stage. The Supreme Court has sanctioned partisan gerrymandering, and the system has evolved to one in which state legislature majorities get to determine who is most likely to fill those seats in Congress.
In short, gerrymandering has become a central feature of the system, not a bug. But what if we rethink the structure entirely?
Fake Hermès Birkin bags and other counterfeit luxury goods are popular not only with people on a budget, but also with those with deeper pockets, a new study suggests.
Researchers from the National University of Singapore analyzed millions of counterfeit purchases by American consumers from more than 24,000 U.S. zip codes on a major cross-border, e-commerce platform. They found that both lower- and higher-income individuals are “significantly more likely” to buy fake luxury items than middle-income consumers, according to a press release by INFORMS on Monday.
The INFORMS Analytics+ Conference showcased how companies are turning advanced analytics and AI into measurable operational results
An audio journey of how data and analytics save lives, save money and solve problems.
Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
Millions of people who got Moderna’s or Johnson & Johnson’s COVID-19 vaccines are expected to soon be lining up for another dose.
Step into one of Maryum Al-Hammami’s Southern California toy stores called The Game Chest, and you'll find the experience is as important as a purchase.
The supply chain disruption is shorthand for problems from factory closures to workers who are not working anymore.
New research in the INFORMS journal Management Science finds that the U.S. Food and Drug Administration (FDA) could enhance public safety by employing new data-driven approaches to identify adverse effects of drugs faster and more reliably, which would improve the regulatory decision-making and oversight processes. This approach would substantially contrast with the current FDA approaches for monitoring drug safety, which suffers major drawbacks (e.g., they are based on voluntary reports that can result in inaccurate or untimely decisions).
Commercial brokers have always crunched data to make sure an investment makes financial sense. But high-tech analytics can take that analysis to a new level.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine